Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127764631 | 12776463 | 1 | I | 201608 | 20160909 | 20160923 | 20160923 | EXP | DE-BFARM-16303956 | DE-TEVA-692145GER | TEVA | 26.00 | YR | F | Y | 0.00000 | 20160923 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127764631 | 12776463 | 1 | PS | NITROFURANTOIN. | NITROFURANTOIN | 1 | 20 MILLIGRAM DAILY; | Y | 91095 | 20 | MG | QD | |||||||
| 127764631 | 12776463 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | AS REQUIRED | U | 71145 | ||||||||||
| 127764631 | 12776463 | 3 | C | Rhinisan | TRIAMCINOLONE ACETONIDE | 1 | 1 DOSAGE FORMS DAILY; | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127764631 | 12776463 | 1 | Urinary tract infection |
| 127764631 | 12776463 | 2 | Pain |
| 127764631 | 12776463 | 3 | Chronic sinusitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127764631 | 12776463 | OT |
| 127764631 | 12776463 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127764631 | 12776463 | Acute hepatic failure | |
| 127764631 | 12776463 | Hypokalaemia | |
| 127764631 | 12776463 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |